Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach
- 15 February 2005
- journal article
- Published by Elsevier in NeuroImage
- Vol. 24 (4) , 1192-1204
- https://doi.org/10.1016/j.neuroimage.2004.10.029
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123i]CNS 1261Nuclear Medicine and Biology, 2004
- Quantification of 5-HT2A Receptors in the Human Brain Using [18F]Altanserin-PET and the Bolus/Infusion ApproachJournal of Cerebral Blood Flow & Metabolism, 2003
- Adenosine and sleepSleep Medicine Reviews, 2002
- Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and MedicationsClinical Pharmacokinetics, 2000
- Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis StudiesJournal of Cerebral Blood Flow & Metabolism, 1997
- Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous InfusionJournal of Cerebral Blood Flow & Metabolism, 1997
- Loss of A1 adenosine receptors in human temporal lobe epilepsyBrain Research, 1996
- Caffeine increases its own metabolism through cytochrome P4501A induction in ratsLife Sciences, 1995
- Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1993
- REMOVAL OF EXOGENOUS TRIGLYCERIDES IN HUMAN FOREARM MUSCLE AND SUBCUTANEOUS TISSUEActa Medica Scandinavica, 1975